Investor Overview

Pardes is a clinical-stage biopharmaceutical company created by and for this moment to solve pandemic-sized problems, starting with COVID-19. We are applying modern reversible-covalent chemistry as a starting point to develop novel drugs while reimagining the patient journey to access these medicines.

Stock
Quote

Webcasts

06/09/2022
at 11:30 AM EDT
03/09/2022
at 11:10 AM PST
02/15/2022
at 3:00 PM PST

Financial Information

Document Date Description Form View

A statement of beneficial ownership of common stock by certain persons

SC 13G View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G View HTML

A statement of beneficial ownership of common stock by certain persons

SC 13G View HTML

An amendment to the SC 13G filing

SC 13G/A View HTML

An amendment to the SC 13G filing

SC 13G/A View HTML

UPLOAD

UPLOAD View HTML

UPLOAD

UPLOAD View HTML

UPLOAD

UPLOAD View HTML

UPLOAD

UPLOAD View HTML

Contact
IR

Send us an investor-related question using the form below.